Geron Corp (GERN) Stock Price, Quote, News & History

GERNNASDAQ
$1.47
-0.065-4.23%
At close: Aug 14, 5:00 PM EST
$1.46
-0.01-0.68%
After Hours: 7:35 PM EST

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-114.38M
Investing Cash Flow (TTM)
94.64M
Financing Cash Flow (TTM)
4.73M
Free Cash Flow (TTM)
-114.76M
Capital Expenditure (TTM)
-386.00K
Net Change in Cash (TTM)
-15.00M

Analyst Rating and Forecast

12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$806.03M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
5.02
PB Ratio (TTM)
4.50
Earnings Yield % (TTM)
-7.17%
Earnings Yield % (FWD)
-3.26%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.34

Company Debt

Total Debt
$120.13M
LT Debt
$120.13M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$62.64M
Debt to Equity
0.56
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.53
Close
$1.47
Volume / Avg.
11.16M / 12.24M
Day Range
$1.44 - $1.53
52 Wk Range
1.04 - 2.01
Market Cap
$936.62M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
51
Short Interest
11.98%
Days to Cover
9.9

About

Sector
Health Care
Industry
Biotechnology
Geron Corp is a biopharmaceutical company focused on blood cancers. Its telomerase inhibitor, RYTELO (imetelstat), is approved in the United States and European Union for certain adult patients with lower-risk myelodysplastic syndromes (LR-MDS) with ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Geron (GERN) stock?

A

You can purchase shares of Geron (NASDAQ:GERN) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Geron (GERN) stock?

A

Geron has a consensus price target of $5.38.

Q

What is the current price for Geron (GERN)?

A

The stock price for Geron (NASDAQ: GERN) is $1.46 last updated August 14, 2026 at 7:35 PM EDT.

Q

Does Geron (GERN) pay a dividend?

A

There are no upcoming dividends for Geron.

Q

When is Geron (NASDAQ:GERN) reporting earnings?

A

Geron does not have any upcoming earnings scheduled.

Q

Is Geron (GERN) going to split?

A

There is no upcoming split for Geron.

Q

What sector and industry does Geron (GERN) operate in?

A

Geron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.